Achieve Life Sciences (ACHV) Change in Receivables (2010 - 2020)
Achieve Life Sciences' (ACHV) quarterly Change in Receivables came in at -$8000.0 in Q1 2020, up 55.56% on a QoQ basis from -$18000.0 in Q4 2018.
Achieve Life Sciences (ACHV) Change in Receivables (2010 - 2020) Analysis & Trends
Achieve Life Sciences (ACHV) has 10 years of Change in Receivables data on file, last reported at -$8000.0 in Q1 2020.
- Quarterly Change in Receivables changed N/A year-over-year to -$8000.0 in Q1 2020, while the trailing twelve-month figure through Sep 2020 was -$26000.0 (changed N/A YoY) and the FY2019 annual result came in at $1000.0, up 150.0% from the prior year.
- Change in Receivables grew to -$8000.0 in Q1 2020, from -$18000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $401000.0 in Q3 2017 to a low of -$241000.0 in Q1 2017.
- A 4-year average of $40181.8 and a median of -$5000.0 in 2018 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2016 — Change in Receivables jumped 31900.0% — and 2017, when it slumped 210.05%.
- Tracing ACHV's Change in Receivables over 4 years: stood at $320000.0 in 2016, then plunged by 148.44% to -$155000.0 in 2017, then surged by 88.39% to -$18000.0 in 2018, then surged by 55.56% to -$8000.0 in 2020.
- The last three Change in Receivables figures came in at -$8000.0 (Q1 2020), -$18000.0 (Q4 2018), and -$5000.0 (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -8,000.00 |
| Mar 31, 2020 | -8,000.00 |
| Dec 31, 2018 | -18,000.00 |
| Dec 31, 2018 | -18,000.00 |
| Sep 30, 2018 | -5,000.00 |
| Sep 30, 2018 | -5,000.00 |
| Dec 31, 2017 | -155,000.00 |
| Dec 31, 2017 | -155,000.00 |
| Sep 30, 2017 | 401,000.00 |
| Sep 30, 2017 | 401,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 4,000.00 |
| Mar 31, 2017 | -241,000.00 |
| Mar 31, 2017 | -241,000.00 |
| Dec 31, 2016 | 320,000.00 |
| Dec 31, 2016 | 320,000.00 |
| Sep 30, 2016 | -149,000.00 |
| Sep 30, 2016 | -149,000.00 |
| Jun 30, 2016 | 74,000.00 |
| Jun 30, 2016 | 74,000.00 |